Valuation: AstraZeneca PLC

Market Cap 293B 261B 240B 218B 413B 27,432B 424B 2,876B 1,146B 14,686B 1,098B 1,075B 46,256B P/E 2026 *
24.7x
P/E 2027 * 21.1x
Enterprise Value 313B 280B 257B 233B 442B 29,358B 453B 3,077B 1,227B 15,717B 1,176B 1,150B 49,503B EV / Sales 2026 *
4.94x
EV / Sales 2027 * 4.54x
Free-Float
96.62%
Yield 2026 *
1.76%
Yield 2027 * 1.88%
1 day+0.98%
1 week+1.49%
Current month+0.76%
1 month+17.24%
3 months+18.24%
6 months+5.41%
Current year+2.00%
1 week 13,458
Extreme 13458
14,312
1 month 11,816
Extreme 11816
14,312
Current year 10,524
Extreme 10524
15,732
1 year 10,524
Extreme 10524
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,090.32
Extreme 8090.32
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Chief Operating Officer 55 01/06/2015
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Date Insider Type Main position Quantity % Market Cap. Importance
6/10/26 Free

See remarks

2 0.0000% -
14/9/26 Free

Chief Financial Officer

73 0.0000%
14/9/26 Buy

Chairman

2,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.98%+1.49%+9.04%+34.78% 289B
+4.28%+0.07%+52.75%+138.78% 1,206B
+2.13%+4.27%+51.21%+91.36% 665B
+0.68%+1.54%+33.83%+112.47% 515B
+2.77%+0.98%+49.44%+68.46% 381B
+1.38%+0.27%+72.42%+45.30% 362B
+0.29%+1.48%+30.84%+58.32% 307B
+1.04%-0.05%+45.29%+76.18% 249B
+1.46%-0.59%+42.48%+125.82% 207B
+1.24%+0.96%-6.32%-60.78% 177B
Average +1.66%+0.45%+38.10%+69.07% 436B
Weighted average by Cap. +2.25%+0.67%+43.87%+89.67%

Financials

2026 *2027 *
Net sales 63.36B 56.55B 52.04B 47.23B 89.51B 5,939B 91.73B 623B 248B 3,179B 238B 233B 10,014B 67.39B 60.16B 55.35B 50.24B 95.21B 6,317B 97.57B 662B 264B 3,382B 253B 248B 10,652B
Net income 11.69B 10.44B 9.6B 8.72B 16.52B 1,096B 16.93B 115B 45.79B 587B 43.89B 42.95B 1,848B 13.58B 12.12B 11.15B 10.12B 19.18B 1,273B 19.66B 133B 53.18B 681B 50.97B 49.88B 2,146B
Net Debt 20.55B 18.34B 16.88B 15.32B 29.03B 1,926B 29.75B 202B 80.46B 1,031B 77.12B 75.47B 3,247B 13.44B 12B 11.04B 10.02B 18.99B 1,260B 19.46B 132B 52.65B 675B 50.46B 49.38B 2,125B
Projected Income Statement - Annual - AstraZeneca PLC
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
09/11/26 GBX 14,066.00 +0.98% 2,147,519
06/11/26 GBX 13,930.00 -0.80% 2,621,001
05/11/26 GBX 14,042.00 +0.13% 5,842,194
04/11/26 GBX 14,024.00 +1.92% 3,827,436
03/11/26 GBX 13,760.00 -0.72% 2,536,689
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - AstraZeneca PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
188.69USD
Average target price
214.61USD
Spread / Average Target
+13.74%